Detalles de la búsqueda
1.
Clinical Utility of Inflammatory and Nutritious Index as Therapeutic Prediction of Nivolumab plus Ipilimumab in Advanced Non-Small Cell Lung Cancer.
Oncology
; 102(3): 271-282, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37725914
2.
Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel.
Oncology
; 102(1): 30-42, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37598676
3.
First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.
Jpn J Clin Oncol
; 54(4): 452-462, 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38271158
4.
Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer.
Int J Clin Oncol
; 29(2): 124-133, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38160406
5.
A Retrospective Study of the Efficacy and Safety of Naldemedine for Treatment of Opioid-Induced Constipation in Patients with Hepatobiliary Pancreatic Cancer.
Medicina (Kaunas)
; 59(3)2023 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36984494
6.
Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.
Invest New Drugs
; 40(5): 1066-1079, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35749041
7.
Post-Progression Survival Highly Influences Overall Survival in Driver Gene Mutation/Translocation Negative or Unknown Type of Non-Small Cell Lung Cancer.
Oncology
; 100(2): 89-100, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34844253
8.
Effects of adding a neurokinin-1 receptor antagonist to 5 mg olanzapine, a 5-hydroxytryptamine-3 receptor antagonist, and dexamethasone for preventing carboplatin-induced nausea and vomiting: a propensity score-matched analysis.
BMC Cancer
; 22(1): 310, 2022 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35321690
9.
Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma.
Chemotherapy
; 67(3): 142-151, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35313303
10.
Low-Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin-Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial.
Oncologist
; 26(6): e1066-e1072, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33811782
11.
Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy.
Oncology
; 99(9): 562-570, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34237736
12.
Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trials.
BMC Cancer
; 21(1): 832, 2021 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34281514
13.
Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with lung cancer.
Jpn J Clin Oncol
; 51(3): 444-450, 2021 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33157554
14.
Efficacy and Safety of Anti-Programed Death-1 Blockade in Previously Treated Large-Cell Neuroendocrine Carcinoma.
Chemotherapy
; 66(3): 65-71, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33827084
15.
Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer.
Int J Clin Oncol
; 26(1): 104-110, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33068220
16.
Clinical Effectiveness of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with a Poor Performance Status.
Medicina (Kaunas)
; 57(11)2021 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34833490
17.
Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations.
Medicina (Kaunas)
; 57(5)2021 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34069436
18.
Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations.
Medicina (Kaunas)
; 57(9)2021 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34577852
19.
Effects of Sex and Seasonal Climatic Changes on the Risk of Incidence of Anti-EGFR Therapy-Induced Rash in Cancer Patients: A Retrospective Study.
Medicina (Kaunas)
; 57(8)2021 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34441007
20.
Real-World Patient Characteristics and Treatment Patterns of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Cancer: A Multicenter Retrospective Chart Review Study.
Medicina (Kaunas)
; 57(11)2021 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34833451